RF13 | PMON159 Long-term Efficacy and Safety Data for Oral Octreotide Capsules in Acromegaly: MPOWERED Trial Open-Label Extension Phase

BACKGROUND: Oral octreotide capsules (OOC) are a treatment option for patients with acromegaly in the United States. The MPOWERED trial (NCT02685709) showed that OOC were noninferior to injectable somatostatin receptor ligands (iSRLs; octreotide or lanreotide) in maintenance of biochemical control i...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleseriu, Maria, Molitch, Mark E, Dreval, Alexander, Pokramovich, Yulia G, Bondar, Irina, Poteshkin, Yury E, Macut, Djuro P, Obermayer-Pietsch, Barbara, Gilgun-Sherki, Yossi, Haviv, Asi, Biermasz, Nienke, Melmed, Shlomo, Strasburger, Christian J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625520/
http://dx.doi.org/10.1210/jendso/bvac150.1205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625520/
http://dx.doi.org/10.1210/jendso/bvac150.1205

Ejemplares similares